‘Normalisation’ towards the No-GDM group was evident following treatment with metformin (Metformin Group), including glucose and insulin, with differences remaining only for total triglycerides and triglycerides in HDL, and alanine (Fig 3). The gene discussed is INS; the disease is gestational diabetes.